CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

Akeso begins Phase III study of cadonilimab for gastric cancer

Phase 3cadonilimabPositive
AI Analysis

Summary

Akeso has initiated enrollment in a global Phase III clinical trial of cadonilimab, a bispecific antibody, for the treatment of advanced gastric cancer.

Clinical Trial Data

Phase

Phase III

Importance:5/10
Sentiment:
0.30
Phase IIIgastric cancerbispecific antibodyclinical trial initiation
Related Companies

Read the original article

Published by Clinical Trials Arena on September 28, 2026 9:24 AM

Read Original